Who are EnFuego Therapeutics's investors?

EnFuego Therapeutics's investors include Cape Fear BioCapital.

How much funding has EnFuego Therapeutics raised?

EnFuego Therapeutics has disclosed $1M raised across 1 round.

EnFuego Therapeutics is headquartered in Pittsboro, US.

Pittsboro, US · Founded 2021 · Delaware corporation · 1 known investors

Paths you didn't know you had: your email and LinkedIn already hold routes to the EnFuego Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Early-stage oncology company developing a breakthrough siRNA platform to target undruggable cancer pathways.

Michael DombeckExecutive

Chad V. PecotNamed on SEC filing

Joe McMahonBoard director

Sue MahonyBoard director

Form D private placements

$1M disclosed across 1 round · 2021

▶$1MraisedOct 2025 · 12 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

What does EnFuego Therapeutics do?: Early-stage oncology company developing a breakthrough siRNA platform to target undruggable cancer pathways.
Who are EnFuego Therapeutics's investors?: EnFuego Therapeutics's investors include Cape Fear BioCapital.
How much funding has EnFuego Therapeutics raised?: EnFuego Therapeutics has disclosed $1M raised across 1 round.
Where is EnFuego Therapeutics headquartered?: EnFuego Therapeutics is headquartered in Pittsboro, US.